Churg-Strauss syndrome and rituximab Archives

Abstract Number: 891 • ACR/ARHP Annual Meeting 2015
Long-Term Use of Rituximab for Eosinophilic Granulomatosis with Polyangiitis
David Theis¹, Carol A. Langford², Gary S. Hoffman³ and Alexandra Villa-Forte⁴, ¹Orthopaedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH, ²Rheumatology, Cleveland Clinic, Cleveland, OH, ³Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Cleveland, OH, ⁴Rheumatology, Cleveland Clinic Foundation, Cleveland, OH
Background/Purpose: Eosinophilic granulomatosis with polyangiitis (EGPA) often presents with persistently active disease requiring chronic glucocorticoid therapy or it may have a relapsing course with partial…
Abstract Number: 2379 • ACR/ARHP Annual Meeting 2012
Successful Treatment of Churg-Strauss Syndrome with Rituximab
Christin Dubrau¹, Fabian Arndt², Wolfgang L. Gross and Frank Moosig⁴, ¹Departement of Rheumatology and Clinical Immunology, University Hospital Schleswig-Holstein, Campus Luebeck and Klinikum Bad Bramstedt, Bad Bramstedt, Germany, ²Departement of rheumatology and clinical immunology, University Hospital Schleswig Holstein and Klinikum Bad Bramstedt, Bad Bramstedt, Germany, ³Vasculitis Clinic, Klinikum Bad Bramstedt & University Hospital of Schleswig Holstein, Bad Bramstedt, Germany
Background/Purpose: Rituximab has recently been shown to be equipotent to cyclophosphamide for induction of remission in generalized ANCA-associated vasculitis. A substantial number of observational pro-…

Abstracts tagged "Churg-Strauss syndrome and rituximab"

Long-Term Use of Rituximab for Eosinophilic Granulomatosis with Polyangiitis

Successful Treatment of Churg-Strauss Syndrome with Rituximab